Monoclonal antibodies
ModeX secures $168M from BARDA to develop antiviral drugs for pandemic threats
Anika Sharma
In yet another remarkable development in the world of biotech, ModeX Therapeutics, in partnership with Merck, has secured a substantial ...
How BCMA-targeted therapies are changing the game for multiple myeloma
SG Tylor
Imagine a world where you could treat cancer with a simple injection or infusion, without the need for surgery, chemotherapy, ...
